Thyme Care’s Series C funding round includes investments from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital.
The post Thyme Care Raises $95M To Advance Cancer Care appeared first on MedCity News.
Leave a comment